Cold Kits Salient Characteristics.pdf
PDF 94 KB Posted
- Attached to
- Radiopharmaceuticals Cold Kits
- Solicitation number
- W91YTZ-21-R-0067
- Issued by
-
Department of the Army Medical Command
About this file
This document outlines the salient characteristics for a federal contract solicitation for radiopharmaceutical cold kits. The solicitation seeks to acquire MDP, SC, mebrofenin, and mertiatide cold kits for use at Dwight D. Eisenhower Army Medical Center at Fort Gordon, Georgia over a one year base period and four option years. The cold kits must be FDA approved drugs, with MDP containing 20 mg medronic acid and mebrofenin containing 45 mg mebrofenin as active ingredients. Related solicitation W91YTZ-21-R-0067 from the Department of the Army Medical Command is for radiopharmaceutical cold kits to be used at the medical center.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| RadioPharm SOW.pdf | ||
| RadioPharmaceuticalsSolicitation_W91YTZ21R0067.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Salient Characteristics
The following statements are to define the salient characteristics of the requirement and were independently determined to describe the minimum needs to satisfy this requirement.
This requirement is for the acquisition of MDP, SC, mebrofenin, and mertiatide cold kits for use in the Nuclear Medicine Department at Dwight D. Eisenhower Army Medical Center (DDEAMC), located at Fort Gordon, Georgia.
Period of Performance: The period of performance is one (1) base year and four (4) option years.
Physical Characteristics/Requirements:
• Must be an FDA approved drugs
• MDP must have 20 mg medronic acid as the active ingredient
• SC must include the kit for radiopharmaceutical preparation
• Mebrofenin must have 45 mg mebrofenin as the active ingredient
Included Services:
Not applicable
File details come from the government source that posted it. Updated .